Learning Objectives: 

1.) Provide the historical framework highlighting methotrexate (MTX) as a potential hepatotoxic medication. 

2.) Review the theorized pathophysiologic considerations of MTX mediated hepatocyte/liver injury. 

3.) Discuss the options to monitor for and detect MTX related hepatotoxicity. 

4.) Review the management of MTX induced liver injury. 

 Disclosures:

- None

CME Code: MANQOR

 Location: virtual (by WebEx only)
Directions: If you are having trouble accessing WebEx, please contact Isaac Smith at isaac.smith063@duke.edu. 

 Streaming: Yes, via WebEx. Link:  https://dukemed.webex.com/meet/is120 

Meeting Number/Access Code: 470 543 135  (you will not need this if you use link above)

Call-in number: 1-650-479-3207